The University of Melbourne Library Digital Repository
metadata only
Receiving enzyme replacement therapy for a lysosomal storage disorder: A preliminary exploration of the experiences of young patients and their families
Medical intervention for lysosomal storage disorders becomes part of life, shaping the reality of the condition for affected individuals and families. Enzyme replacement therapy (ERT) is available to treat some lysosomal storage disorders. ERT is costly and time consuming, requiring frequent hospita
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Molecular and Cellular Mechanisms of Lysosomal Storage Diseases#915531
- Exome sequencing to identify the genetic bases for lysosomal storage diseases of unknown etiology#1017709
- A Gaucher Disease Gene Therapy Trial With FLT201#916919
- Screening of Lysosomal Storage Disorders Diseases in Minority Groups#800906
- The Efficacy and Safety of Switch Between Agalsidase Beta to Agalsidase Alfa for Enzyme Replacement in Patients With Anderson-Fabry Disease#848401
Record · ID 1005431
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive